Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbd1d44888f5b41142d83de455096387 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b7a5c546db0678dbd6f9594fc43f2d6 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate |
2018-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fddb7c39193eaccaa5a563f9c297e4ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd5a0814dc7d2b04039f27bbb74390b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a82785dd205dda2dde69423a9ce97d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c419d02cb165033b60e81fe5c85f5659 |
publicationDate |
2018-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10144749-B2 |
titleOfInvention |
Gold complexes of alkylated phosphines |
abstract |
Gold(I) complex with mixed ligands as an anticancer agent. The gold(I) ion is coordinated to a dithiocarbamate ligand and a phosphorus-containing ligand (e.g. phosphines). Also described are a pharmaceutical composition incorporating the gold(I) complex, a methods of synthesizing the gold(I) complex, and a method for treating cancer. |
priorityDate |
2016-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |